NAD+ in Brain Aging and Neurodegenerative...
Iporuru 14 Nov 2019
Attached Files
Iporuru 14 Nov 2019
The probable connections between NAD and Alzheimer’s, Parkinson’s, ALS, and Huntington’s diseases are explained in this figure.
Attached Files
ambivalent 06 Dec 2019
There was some reporting of positive effects of NR on a neurodegenerative disorders a couple of years ago:
https://www.longecit...e-4#entry833268
MikeDC 12 Dec 2019
Tam 17 Dec 2019
I am a caregiver for someone with symptoms of ALS (no diagnosis at this time).
One of the hallmarks of ALS is that it is easy to lose weight, and very difficult or even impossible to gain weight.
Statistically, persons with ALS (PALS) have a better life expectancy if they are a little overweight rather than normal weight.
Having read/scanned the 20-page thread dedicated to personal experience with NMN, it seems that many people report rapid and effortless weight loss. Of course, this is desirable for many people.
My question is: Is there any experience or information regarding a situation in which the person does not want to lose weight, and actually wants to gain weight instead, including both muscle and fat?
Thanks!
bluemoon 17 Dec 2019
One study of NR on cognitive impairment and sleep quality will be published soon.
That Chromadex study was completed in April so won't be published until 2021. Not exactly "soon."
MikeDC 17 Dec 2019
That Chromadex study was completed in April so won't be published until 2021. Not exactly "soon."
Just because their last clinical trial took two year to publish, it doesn’t mean this one will take that long. Normally 10 month is enough time.
bluemoon 17 Dec 2019
Just because their last clinical trial took two year to publish, it doesn’t mean this one will take that long. Normally 10 month is enough time.
So far, Elysium has been the fastest to publish at 15 months so there is no reason to think Chrmadex will be 10 months after 24 month lag periods.
We can expect those results sometime between next August and April 2021, neither of which are soon.